International Prostate Cancer Foundation

A new study published reveals that the prostate as a whole, including cells that appear normal, is different in men with prostate cancer.

It suggests that tissue cells throughout the whole prostate are primed and ready to develop prostate cancer.

Read more on the News section of the IPCF website.

Researchers at the University of East Anglia have made an important discovery about how prostate cancer may start to develop — International Prostate Cancer Foundation repost: University of East Anglia A new study published today reveals that the prostate as a whole, including cells that appear normal, is different in men with prostate cancer. It suggests that tissue cells throughout the whole prostate are primed and ready to develop prostate cancer. This mea

New breakthroughs being made in immunotherapy for prostate cancer. Visit the link below to read more.

www.fightingprostatecancer.org/blog/2025/10/29/whats-new-in-immunotherapy-for-prostate-cancer

A less expensive, more accessible, and comfortable alternative exists for those facing a prostate cancer biopsy, according to findings from a new clinical trial that Yale Urology contributed to.

Authors say OPTIMUM, the first head-to-head trial comparing micro-ultrasound-guided versus MRI-guided biopsies, signifies a breakthrough in image-guided treatment.

Read more in the news section of the website. Or click the link below.

Breakthrough Study in Image-Guided Prostate Cancer Treatment — International Prostate Cancer Foundation article repost from Yale School of Medicine (click for source article) by Cheri Lewis A less expensive, more accessible, and comfortable alternative exists for those facing a prostate cancer biopsy, according to findings from a new clinical trial that Yale Urology contributed to. Authors say

Study reveals significant improvement in reducing prostate cancer progression without compromising quality of life.

New Prostate Cancer Treatment Approach Slows Progression Without Hurting Quality of Life, Study Finds — International Prostate Cancer Foundation article repost: University of Kansas Cancer Center (click for source article) Study reveals significant improvement in reducing prostate cancer progression without compromising quality of life. The 5-year survival rate for local or regional prostate cancer is nearly 100%, but the rate drops to 3

Schedule your PSA Screening today! The researchers maintain that the similarities between the two forms of screening mean it is no longer rational to reject prostate cancer screening on one hand while endorsing screening for breast cancer on the other.

New research shows: Prostate cancer screening as good as breast cancer screening — International Prostate Cancer Foundation below is an excerpt from a press release by European Association of Urology Congress (EAU26) in London. See the full press release here.

It's International Prostate Cancer Day in Orlando, Florida! In honor of that, talk to a man in your life about his plan for a PSA screening or DRE!

The International Prostate Cancer Foundation sends it’s deepest condolences to the family of College Football Hall of Fame Coach and IPCF Survivor Lou Holtz.

We share in their sadness as they announce his passing.

www.fightingprostatecancer.org/blog/2026/3/5/college-football-hall-of-fame-coach-and-ipcf-survivor-lou-holtz-passes-away-at-age-89

Did you know? Black men continue to face disproportionate risks from prostate cancer. Know your risks. Make a plan, schedule a PSA screening today.

It's Black History Month. Did you know that Prostate Cancer is more common in Black Men? This is a good time to make a plan to get tested.

During last nights Super Bowl Novartis and the NFL teamed up for a commercial promoting PSA testing and Prostate Cancer Awareness. Visit the news section of the IPCF website for our recommended screening guidelines and to see the commercial aired during last night's game.

NFL and Novartis team up to address Prostate Cancer Myths and PSA testing at Super Bowl LX: "Relax, It's a Blood Test" — International Prostate Cancer Foundation The National Football League and Novartis, a leading global innovative medicines company, launches a new awareness initiative timed to Super Bowl LX, starting the conversation to make critical health information clearer, accessible and relevant.